Non-Hodgkin lymphoma screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Preeti Singh (talk | contribs) No edit summary |
||
| Line 2: | Line 2: | ||
{{Non-Hodgkin lymphoma}} | {{Non-Hodgkin lymphoma}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Preeti}} | ||
==Overview== | ==Overview== | ||
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma. | According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma. | ||
| Line 11: | Line 11: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
Latest revision as of 00:53, 20 January 2019
|
Non-Hodgkin lymphoma Microchapters |
|
Differentiating Non-Hodgkin's Lymphoma |
|---|
|
Treatment |
|
Case Studies |
|
Non-Hodgkin lymphoma screening On the Web |
|
American Roentgen Ray Society Images of Non-Hodgkin lymphoma screening |
|
Risk calculators and risk factors for Non-Hodgkin lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Overview
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma.
Screening
According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for Non-Hodgkin lymphoma.